Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Conducting Process Validation for MDIs

Posted on By

SOP for Conducting Process Validation for MDIs

Process Validation Procedures for MDIs

1) Purpose

The purpose of this SOP is to establish procedures for conducting process validation for the manufacturing of metered-dose inhalers (MDIs) to ensure consistency, reliability, and compliance with regulatory requirements.

2) Scope

This SOP applies to all personnel involved in process validation activities within the MDI production facility, including production engineers, quality assurance personnel, and validation specialists.

3) Responsibilities

The responsibilities for this SOP include planning validation studies, executing validation protocols, analyzing validation data, and documenting validation activities. Specific roles include:
Production Engineers: Implement validated processes in production operations.
Quality Assurance Personnel: Review and approve validation protocols and reports.
Validation Specialists: Conduct validation studies and analyze validation data.

See also  SOP for Quality Control Testing of MDIs

4) Procedure

4.1 Process Validation Planning
4.1.1 Define the scope and objectives of process validation studies.
4.1.2 Identify critical process parameters (CPPs) and critical quality attributes (CQAs).
4.2 Protocol Development
4.2.1 Develop validation protocols detailing study objectives, test methods, acceptance criteria, and sampling plans.
4.2.2 Obtain approval of validation protocols from relevant stakeholders.
4.3 Process Qualification
4.3.1 Perform Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ)

as applicable.
4.3.2 Document and analyze qualification results to ensure process capability and equipment performance.
4.4 Continued Process Verification
4.4.1 Implement a strategy for ongoing monitoring and verification of validated processes.
4.4.2 Collect and analyze data to confirm continued process control and product quality.
4.5 Validation Reporting
4.5.1 Prepare validation reports summarizing study results, conclusions, and any deviations encountered.
4.5.2 Archive validation documentation for future reference and regulatory inspections.

See also  SOP for Cleaning Validation in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
SOP: Standard Operating Procedure
CPPs: Critical Process Parameters
CQAs: Critical Quality Attributes
IQ: Installation Qualification
OQ: Operational Qualification
PQ: Performance Qualification

6) Documents, if any

Validation protocols, qualification reports, process validation reports, and ongoing monitoring plans should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for process validation requirements in pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Cream Mixing Vessel
Next Post: SOP for Raw Material Inspection for Granules

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version